PACS financial statements and SEC filings
PACS annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $5.29B | $309.60M | $191.54M | 10-K |
| 2024-12-31 | $4.09B | $123.07M | $55.76M | 10-K |
| 2023-12-31 | $3.11B | $207.77M | $112.87M | 10-K |
| 2022-12-31 | $2.42B | $229.36M | $150.50M | 10-K |
PACS annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $5.58B | $4.63B | $952.45M | 10-Q |
| 2024-12-31 | $5.24B | $4.53B | $715.69M | 10-K |
| 2023-12-31 | $3.51B | $3.41B | $101.73M | 10-K |
PACS annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $404.22M | -$105.41M | -$68.99M | 10-K |
| 2024-12-31 | $367.34M | -$66.47M | $117.48M | 10-K |
| 2023-12-31 | $63.70M | -$45.78M | $129.59M | 10-K |
| 2022-12-31 | $92.61M | -$22.86M | $12.35M | 10-K |